Journal article
Imaging guiding therapy development in lymphoma
Clinical pharmacology and therapeutics, Vol.84(4), pp.443-445
10/2008
DOI: 10.1038/clpt.2008.167
PMID: 18802425
Abstract
Radiographic imaging has deep roots as a surrogate for efficacy in guiding decisions in therapy development in lymphoma. Nodal lymphomas are generally easy to measure in two dimensions and frequently shrink promptly when exposed to therapies that result in long-term clinical usefulness. New therapies in lymphoma are still required to induce radiographic response to be considered useful in a paradigm dating back at least to chest roentgenograms and Hodgkin's lymphoma (HL). This paradigm will soon be challenged by new therapeutic strategies under development, but creative imaging approaches can still guide such development.
Details
- Title: Subtitle
- Imaging guiding therapy development in lymphoma
- Creators
- B K Link - Holden Comprehensive Cancer Center, Division of Hematology Oncology, Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA. brian-link@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- Clinical pharmacology and therapeutics, Vol.84(4), pp.443-445
- DOI
- 10.1038/clpt.2008.167
- PMID
- 18802425
- ISSN
- 0009-9236
- eISSN
- 1532-6535
- Language
- English
- Date published
- 10/2008
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984094390902771
Metrics
10 Record Views